TrialInvestigational new drugs2012
A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer.
Daniel J Renouf et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it